Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Sunoco Inc. ( ) announced plans to boost the storage capacity of the Eagle Point Terminal in Westville, New Jersey, in order to ensure a stable supply of refined products in the region.
The Eagle Point refinery, which has 3 million barrels of active storage, will have an additional capacity of 2 million barrels in 2012. The unit will still have more storage capacity available to return to service.
Sunoco also expanded Eagle Point's deep water marine docks to handle large tankers of 600,000 barrel capacity (AfraMax) and 1 million barrel capacity (SuezMax). The railcar offloading platform at the facility was also upgraded.
In order to sustain smooth supply to the Northeast markets, interconnecting pipelines were installed between Eagle Point and the Colonial Pipeline, Laurel Pipeline and Harbor Pipeline systems. Management has also laid plans to reverse pipelines that could transport imports from the New York Harbor down to Philadelphia.
Sunoco's plans to sell off or idle the Marcus Hook and Philadelphia refineries and exit the refining business has become a matter of concern for people regarding short-supply of products in the Northeast. This initiative of the company assures the retail network as well as commercial customers of a steadfast delivery of gasoline, diesel and other products.
We have a long-term Underperform rating on the stock, considering Sunoco's weak business model, geographically undiversified asset base and operational hindrances. Our pessimistic outlook also stems from the company's poorly performing refining and supply segment, which registered a high loss along with lower realized prices and throughputs in the fourth quarter of 2011.
Additionally, in mid-January, Sunoco completed the separation of its metallurgical coke manufacturing business, to SunCoke Energy Inc. ( SXC - Snapshot Report ) , a 100% publicly traded company. We believe that the transfer of SunCoke has made Sunoco a less diversified business model. As a result, Sunoco is exposed to greater competitive risks than it was prior to the spin-off.
Hence, we expect Sunoco to perform below the industry, which gives investors little reason to hold the stock.
Read the full reports :
Snapshot Report on SXC
Snapshot Report on SCX